[Disclosure] Alteogen (196170) to List 146,140 Additional Common Shares Following Stock Option Exercises

Source Fact: Financial Supervisory Service Electronic Disclosure System (DART) / 2025-05-23

Disclosure Type: Additional Listing (Exercise of Stock Options)

💡 3-Second Summary

Alteogen will list an additional 146,140 common shares on May 28, which were newly issued following the exercise of stock options by its executives and employees.

📊 1. [Summary of Core Disclosure Content and Key Figures]

• Type and Quantity of Additional Shares: 146,140 Common Shares
• Reason for Additional Listing: Exercise of Stock Options (Stock Purchase Rights)
• Detailed Breakdown by Tranche (Exercise Date: May 16, 2025):
  • 107th Tranche: 60,000 shares (Exercise Price: KRW 8,917)
  • 108th Tranche: 20,000 shares (Exercise Price: KRW 21,111)
  • 109th Tranche: 4,000 shares (Exercise Price: KRW 23,833)
  • 110th Tranche: 40,000 shares (Exercise Price: KRW 63,889)
  • 111th Tranche: 7,200 shares (Exercise Price: KRW 72,875)
  • 112th Tranche: 7,200 shares (Exercise Price: KRW 62,858)
  • 113th Tranche: 7,740 shares (Exercise Price: KRW 47,417)
• Par Value per Share: KRW 500
• Listing Date: May 28, 2025
• Total Number of Listed Shares After Additional Listing: 53,464,968 Common Shares
• Dividend Baseline Date: January 1, 2025

📈 2. [Expert Perspective: What This Disclosure Means for Investors]

This disclosure functions as an administrative notification regarding the issuance and upcoming listing of new shares following staff stock option exercises. The execution of these rights is an internal compensation matter and does not directly reflect changes in operational performance or core corporate Fundamental.

Investors should primarily assess the metrics of equity dilution and potential near-term overhang risks. The 146,140 additional shares represent approximately 0.27% of the total outstanding share volume post-listing (53,464,968 shares). Due to this small proportion, the potential dilutive impact on overarching shareholder value is likely to be highly limited. However, because certain tranches carry lower exercise prices (ranging down to KRW 8,917), some profit-taking sales may occur after the May 28 listing date, meaning investors may track this for minor short-term liquidity fluctuations.

📝 Editor’s Comment (by K-STOCK Editor)

Corporate talent is cashing in on rewards as Alteogen’s growth journey charges ahead! A total of 146,140 shares—including some highly lucrative low-priced tranches like the KRW 8,917 block—are coming to the market on May 28. Since this volume accounts for a mere 0.27% of Alteogen’s total 53.4 million share base, it is far too minor to disrupt the stock’s macro momentum. While some immediate profit-taking might spark light selling pressure, standard market liquidity should seamlessly absorb the blocks. It is best viewed as a routine operational reward milestone.

📢 Disclaimer and Source Information

Source: This content has been newly structured and written based on the official data submitted to the Financial Supervisory Service Electronic Disclosure System (DART).

Investment Risk Notice: This content is provided solely for information and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Inquiries: For compliance-related inquiries or copyright requests, please contact ksb220805@gmail.com.